The introduction of eConsent and biobanking systems has changed how biosamples are tracked and attributed. In a recent webinar, Dr Jian Wang and Eric Delente (IQVIA) discussed how eConsent can be applied in the biobanking realm. They also reviewed how the attributes of consent documents relevant to biosamples can move organizations away from error-prone spreadsheet trackers, towards more secure and transparent processes. Download the presentation to learn more.
Related Insights
Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials
Consent Tracking for Clinical Trial Samples
Optimizing the management of consents throughout the entire lifecycle
Tracking Clinical Trial Samples
Optimizing the management of samples throughout the entire lifecycle
Blockchain in Clinical Research Sample Management
Distributed Ledger Technology (DLT) in clinical trials
Managing Sample Data from Vendors
Best Practices for Clinical Trials
Using Labmatrix® at a Big Biopharma Company to Reduce Clinical Trial Delays, Costs and Regulatory Risks
Managing Sample Data from Vendors
Best practices for clinical trials
Key Central Laboratory Capabilities to Enable Successful Immuno-Oncology Clinical Development
Trends and recommendations in laboratory selection
Best practices in clinical trial sample and consent lifecycle management
Clinical Trial Biospecimen and Consent Tracking
Learn about the BioFortis solution for addressing new challenges around sample and consent tracking
